Assessment of RIFLE and AKIN criteria to define acute renal dysfunction for HIPEC procedures for ovarian and non ovarian peritoneal malignances

被引:28
作者
Arjona-Sanchez, A. [1 ,2 ]
Cadenas-Febres, A. [1 ]
Cabrera-Bermon, J. [1 ]
Munoz-Casares, F. C. [1 ,2 ]
Casado-Adam, A. [1 ]
Sanchez-Hidalgo, J. M. [1 ,2 ]
Lopez-Andreu, M. [3 ]
Briceno-Delgado, J. [1 ,2 ]
Rufian-Pena, S. [1 ,2 ]
机构
[1] Univ Hosp Reina Sofia, Unit Oncol & Pancreat Surg, Av Menendez Pidal S-N, Cordoba 14004, Spain
[2] Univ Hosp Reina Sofia, CIBERehd, IMIBIC, Cordoba, Spain
[3] Univ Hosp Reina Sofia, Nephrol Unit, Cordoba, Spain
来源
EJSO | 2016年 / 42卷 / 06期
关键词
Acute renal failure; RIFLE; HIPEC; Peritoneal carcinomatosis; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ACUTE KIDNEY INJURY; CYTOREDUCTIVE SURGERY; CARCINOMATOSIS; MORBIDITY; MORTALITY; OUTCOMES;
D O I
10.1016/j.ejso.2015.12.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The acute renal dysfunction (ARD) is a common complication in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Our aim is evaluate the ARD post-HIPEC procedures using the RIFLE and AKIN criteria. Evaluate the risk factors and analyze ARD's impact on postoperative course. Methods: From 2011 to 2014, in a retrospective way using a prospective database were operated by HIPEC procedure. The ARD was analyzed by RIFLE and AKIN criteria. The perioperative features were analyzed and a multivariate analysis was performed to define the risk factors to develop the ARD. Results: 141 patients were treated and analyzed. The ARD was detected in 30.5% (Injury 18.4% and Failure 12.1%) when RIFLE criteria were applied. The multivariate analysis detected that decrease of pH during HIPEC [OR = 29.39 (5.09-169.76)], PCI [OR = 1.07 (1.01-1.15)] and ureteral catheters [OR = 12.71 (1.44-111.85)] were associated to the development of acute renal injury (ARI) post-HIPEC. Decrease of Na during HIPEC [OR = 1.15 (1.01-1.30)], intraoperative inotrope use [OR = 3.83 (1.12-13.09)] and PCI [OR = 1.06 (1.0-1.14)] were associated to acute renal failure (ARF) post-HIPEC. The ARD was related to a higher length of stay hospital (17.2 +/- 11 vs. 13.8 +/- 8 days) (p = 0.05) but no impact in early survival was observed in ARD group. Conclusions: The widespread use of RIFLE criteria for ARD would have major benefits in terms of accurately diagnosing patients undergone HIPEC procedures. The ARD has a detrimental impact in length of stay hospital. The knowledge of risk factors helps us to prevent the ARD post-HIPEC by means of an aggressive and multidisciplinary perioperative management. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:869 / 876
页数:8
相关论文
共 25 条
  • [1] Outcome of Patients with Aggressive Pseudomyxoma Peritonei Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy
    Arjona-Sanchez, Alvaro
    Cristobal Munoz-Casares, Francisco
    Casado-Adam, Angela
    Manuel Sanchez-Hidalgo, Juan
    Ayllon Teran, Maria Dolores
    Orti-Rodriguez, Rafael
    Cristina Padial-Aguado, Ana
    Medina-Fernandez, Javier
    Ortega-Salas, Rosa
    Pulido-Cortijo, Gema
    Gomez-Espana, Auxiliadora
    Rufian-Pena, Sebastian
    [J]. WORLD JOURNAL OF SURGERY, 2013, 37 (06) : 1263 - 1270
  • [2] Morbidity and Mortality of Cytoreduction with Intraperitoneal Chemotherapy: Outcomes from the ACS NSQIP Database
    Bartlett, Edmund K.
    Meise, Chelsey
    Roses, Robert E.
    Fraker, Douglas L.
    Kelz, Rachel R.
    Karakousis, Giorgos C.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) : 1494 - 1500
  • [3] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo, R
    Ronco, C
    Kellum, JA
    Mehta, RL
    Palevsky, P
    [J]. CRITICAL CARE, 2004, 8 (04): : R204 - R212
  • [4] Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    Canda, Aras Emre
    Sokmen, Selman
    Terzi, Cem
    Arslan, Cigdem
    Oztop, Ilhan
    Karabulut, Bulent
    Ozzeybek, Deniz
    Sarioglu, Sulen
    Fuzun, Mehmet
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (04) : 1082 - 1087
  • [5] Effect of perfusion temperature on glucose and electrolyte transport during hyperthermic intraperitoneal chemoperfusion (HIPEC) with oxaliplatin
    Ceelen, W.
    De Somer, F.
    Van Nieuwenhove, Y.
    Vande Putte, D.
    Pattyn, P.
    [J]. EJSO, 2013, 39 (07): : 754 - 759
  • [6] Should the Treatment of Peritoneal Carcinomatosis by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Still be Regarded as a Highly Morbid Procedure? A Systematic Review of Morbidity and Mortality
    Chua, Terence C.
    Yan, Tristan D.
    Saxena, Akshat
    Morris, David L.
    [J]. ANNALS OF SURGERY, 2009, 249 (06) : 900 - 907
  • [7] Ureteral Stenting in Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy as a Routine Procedure: Evidence and Necessity
    Coccolini, Federico
    Lotti, Marco
    Manfredi, Roberto
    Catena, Fausto
    Vallicelli, Carlo
    De Iaco, Pier Andrea
    Da Pozzo, Luigi
    Frigerio, Luigi
    Ansaloni, Luca
    [J]. UROLOGIA INTERNATIONALIS, 2012, 89 (03) : 307 - 310
  • [8] Population Pharmacokinetics and Pharmacodynamics of Cisplatinum During Hyperthermic Intraperitoneal Chemotherapy Using a Closed Abdominal Procedure
    Cotte, Eddy
    Colomban, Olivier
    Guitton, Jerome
    Tranchand, Brigitte
    Bakrin, Nawel
    Gilly, Francois-Noel
    Glehen, Olivier
    Tod, Michel
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (01) : 9 - 18
  • [9] The incidence of cisplatin nephrotoxicity post hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery
    Hakeam, Hakeam A.
    Breakiet, Mohammed
    Azzam, Ayman
    Nadeem, Ashraf
    Amin, Tarek
    [J]. RENAL FAILURE, 2014, 36 (10) : 1486 - 1491
  • [10] RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis
    Hoste, Eric A. J.
    Clermont, Gilles
    Kersten, Alexander
    Venkataraman, Ramesh
    Angus, Derek C.
    De Bacquer, Dirk
    Kellum, John A.
    [J]. CRITICAL CARE, 2006, 10 (03):